471 related articles for article (PubMed ID: 2570761)
1. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma.
Edelman DA
Int J Fertil; 1989; 34(4):251-5. PubMed ID: 2570761
[TBL] [Abstract][Full Text] [Related]
2. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
[TBL] [Abstract][Full Text] [Related]
3. The current status of the DES-exposed population.
Herbst AL
Obstet Gynecol Annu; 1981; 10():267-78. PubMed ID: 7024873
[TBL] [Abstract][Full Text] [Related]
4. Genital clear cell adenocarcinoma.
Johnston GA; Jones HA
Int Surg; 1983; 68(3):257-61. PubMed ID: 6662641
[TBL] [Abstract][Full Text] [Related]
5. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).
Barclay DL
J Ark Med Soc; 1979 May; 75(12):451-2. PubMed ID: 156173
[TBL] [Abstract][Full Text] [Related]
6. DES exposure and the aging woman: mothers and daughters.
Laitman CJ
Curr Womens Health Rep; 2002 Oct; 2(5):390-3. PubMed ID: 12215312
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological studies of the effects of diethylstilboestrol.
Vessey MP
IARC Sci Publ; 1989; (96):335-48. PubMed ID: 2680951
[TBL] [Abstract][Full Text] [Related]
8. Management of the adolescent girl exposed in utero to DES.
Gerbie MV
Pediatr Ann; 1981 Dec; 10(12):23-6. PubMed ID: 7335401
[TBL] [Abstract][Full Text] [Related]
9. The effects in the human of diethylstilbestrol (DES) use during pregnancy.
Herbst AL
Princess Takamatsu Symp; 1987; 18():67-75. PubMed ID: 3506546
[TBL] [Abstract][Full Text] [Related]
10. Primary non-clear-cell adenocarcinomas of the vagina in older DES-exposed women.
DeMars LR; Van Le L; Huang I; Fowler WC
Gynecol Oncol; 1995 Sep; 58(3):389-92. PubMed ID: 7672708
[TBL] [Abstract][Full Text] [Related]
11. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update.
Melnick S; Cole P; Anderson D; Herbst A
N Engl J Med; 1987 Feb; 316(9):514-6. PubMed ID: 3807995
[TBL] [Abstract][Full Text] [Related]
12. Physical and psychological effects of DES on exposed offspring.
Konicki AM
Cancer Nurs; 1985 Aug; 8(4):233-7. PubMed ID: 3850790
[No Abstract] [Full Text] [Related]
13. Development of clear cell adenocarcinoma in DES-exposed offspring under observation.
Kaufman RH; Korhonen MO; Strama T; Adam E; Kaplan A
Obstet Gynecol; 1982 Jun; 59(6 Suppl):68S-72S. PubMed ID: 7088431
[TBL] [Abstract][Full Text] [Related]
14. Identification and management of DES-exposed women.
Vieiralves-Wiltgen C; Engle VF
Nurse Pract; 1988 Nov; 13(11):15-6, 19-20, 22 passim. PubMed ID: 3231355
[TBL] [Abstract][Full Text] [Related]
15. Diethylstilbestrol in pregnancy: an update.
Kinch RA
Can Med Assoc J; 1982 Nov; 127(9):812-3. PubMed ID: 7139494
[TBL] [Abstract][Full Text] [Related]
16. [A case of vaginal adenocarcinoma after uterine exposure to diethylstilbestrol].
Schreiner WE; Bronz L; Wyss-Bernet M; Genton CY
Schweiz Med Wochenschr; 1985 Nov; 115(44):1555-61. PubMed ID: 3841230
[TBL] [Abstract][Full Text] [Related]
17. [Teratogenic effect of diethylstilbestrol during pregnancy; the extent of the DES problem in the Netherlands].
Stolk JG; Vooijs GP; Aartsen EJ; Heintz AP
Ned Tijdschr Geneeskd; 1982 Jul; 126(30):1350-8. PubMed ID: 7133167
[No Abstract] [Full Text] [Related]
18. Diethylstilbestrol exposure in utero: review of literature.
Glaze GM
J Am Osteopath Assoc; 1984 Feb; 83(6):435-8. PubMed ID: 6368486
[TBL] [Abstract][Full Text] [Related]
19. DES clinic--the first six months.
Wingfield M; Donnelly VS; Kelehan P; Stronge JM; Murphy J; Boylan P
Ir Med J; 1992 Jun; 85(2):56-8. PubMed ID: 1628942
[TBL] [Abstract][Full Text] [Related]
20. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol.
Newbold RR; McLachlan JA
Cancer Res; 1982 May; 42(5):2003-11. PubMed ID: 7066910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
